243 related articles for article (PubMed ID: 20347808)
1. Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.
Frampton G; Coufal M; Li H; Ramirez J; DeMorrow S
Exp Cell Res; 2010 May; 316(9):1465-78. PubMed ID: 20347808
[TBL] [Abstract][Full Text] [Related]
2. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
DeMorrow S; Glaser S; Francis H; Venter J; Vaculin B; Vaculin S; Alpini G
J Biol Chem; 2007 Apr; 282(17):13098-113. PubMed ID: 17329257
[TBL] [Abstract][Full Text] [Related]
3. Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor.
Huang L; Ramirez JC; Frampton GA; Golden LE; Quinn MA; Pae HY; Horvat D; Liang LJ; DeMorrow S
Lab Invest; 2011 Jul; 91(7):1007-17. PubMed ID: 21464819
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats.
Tanveer R; Gowran A; Noonan J; Keating SE; Bowie AG; Campbell VA
J Biol Chem; 2012 Oct; 287(41):34709-21. PubMed ID: 22891244
[TBL] [Abstract][Full Text] [Related]
5. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
[TBL] [Abstract][Full Text] [Related]
6. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR
PLoS One; 2013; 8(10):e77433. PubMed ID: 24204826
[TBL] [Abstract][Full Text] [Related]
7. Scabraside D Extracted from Holothuria scabra Induces Apoptosis and Inhibits Growth of Human Cholangiocarcinoma Xenografts in Mice.
Assawasuparerk K; Vanichviriyakit R; Chotwiwatthanakun C; Nobsathian S; Rawangchue T; Wittayachumnankul B
Asian Pac J Cancer Prev; 2016; 17(2):511-7. PubMed ID: 26925636
[TBL] [Abstract][Full Text] [Related]
8. Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts.
Assawasuparerk K; Rawangchue T; Phonarknguen R
Asian Pac J Cancer Prev; 2016; 17(4):2151-7. PubMed ID: 27221911
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway.
DeMorrow S; Francis H; Gaudio E; Venter J; Franchitto A; Kopriva S; Onori P; Mancinelli R; Frampton G; Coufal M; Mitchell B; Vaculin B; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1150-8. PubMed ID: 18832445
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.
Okabe H; Beppu T; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Jono H; Ueda M; Shinriki S; Ando Y; Baba H
Ann Surg Oncol; 2011 Apr; 18(4):1175-84. PubMed ID: 21042948
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.
Hong SM; Park CW; Cha HJ; Kwon JH; Yun YS; Lee NG; Kim DG; Nam HG; Choi KY
Clin Exp Metastasis; 2013 Feb; 30(2):177-87. PubMed ID: 22875246
[TBL] [Abstract][Full Text] [Related]
12. HDAC6 inhibition restores ciliary expression and decreases tumor growth.
Gradilone SA; Radtke BN; Bogert PS; Huang BQ; Gajdos GB; LaRusso NF
Cancer Res; 2013 Apr; 73(7):2259-70. PubMed ID: 23370327
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.
Lee GR; Jang SH; Kim CJ; Kim AR; Yoon DJ; Park NH; Han IS
Clin Exp Metastasis; 2014 Dec; 31(8):897-907. PubMed ID: 25217963
[TBL] [Abstract][Full Text] [Related]
14. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.
Maccarrone M; Rossi S; Bari M; De Chiara V; Fezza F; Musella A; Gasperi V; Prosperetti C; Bernardi G; Finazzi-Agrò A; Cravatt BF; Centonze D
Nat Neurosci; 2008 Feb; 11(2):152-9. PubMed ID: 18204441
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
16. Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function.
Das I; Craig C; Funahashi Y; Jung KM; Kim TW; Byers R; Weng AP; Kutok JL; Aster JC; Kitajewski J
J Biol Chem; 2004 Jul; 279(29):30771-80. PubMed ID: 15123653
[TBL] [Abstract][Full Text] [Related]
17. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
18. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
[TBL] [Abstract][Full Text] [Related]
19. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.
Mancarella S; Serino G; Dituri F; Cigliano A; Ribback S; Wang J; Chen X; Calvisi DF; Giannelli G
Cell Death Differ; 2020 Aug; 27(8):2330-2343. PubMed ID: 32042099
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M
J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
